# Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -

> **NCT01793688** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 982 (actual)

## Conditions studied

- Pneumonia
- Lung Abscess
- Peritonitis

## Interventions

- **DRUG:** Sulbactam Sodium/Ampicillin Sodium

## Key facts

- **NCT ID:** NCT01793688
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-12
- **Primary completion:** 2016-01-27
- **Final completion:** 2016-01-27
- **Target enrollment:** 982 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793688, "Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01793688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*